Form D · Pharmaceuticals

Inozyme Pharma, Inc.

Boston, MA · CIK 0001693011

Offering snapshot reported Jun 8, 2020 · SEC filing

Reported sold
$67.4M
Offering amount: $67.4M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 9, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$33.7M$67.4MNov 21, 2018: $10,699,996.00Nov 21, 2018Mar 29, 2019: $33,699,996.00Mar 29, 2019Mar 27, 2020: $33,699,996.00Jun 8, 2020: $67,399,993.00Jun 8, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$33,699,996 → $67,399,993
  • Reported investors11 → 12

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 8, 2020Amendment$67,399,993$33,699,997vs Mar 27, 202012SEC filing
Mar 27, 2020Amendment$33,699,996$0vs Mar 29, 201911SEC filing
Mar 29, 2019Amendment$33,699,996$23,000,000vs Nov 21, 201811SEC filing
Nov 21, 2018Initial$10,699,996No comparison5SEC filing
Nov 21, 2018Amendment$48,850,000No comparison14SEC filing
Jan 12, 2017AmendmentYet to sellNo comparison0SEC filing
Jan 5, 2017InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-326389

Source: Form D, filed Jun 8, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sarah Bhagat Director
Axel Bolte Director, Executive
Reinaldo Diaz Director
Martin Edwards Director
Rob Hopfner Director
Edward Mathers Director
Joseph Schlessinger Director
Lynne Sullivan Director
Douglas Treco Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
321 Summer Street Suite 400
Boston, MA, 02210